CLINICAL_TRIALS
trial_result
· 2021-04-01
Clinical Trial Update: Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean [Phase 3]
Summary
Phase 3 trial comparing lasmiditan to placebo for acute treatment of migraine in Korean population has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Acute Migraine | Phase 3 | Status: COMPLETED